Core Laboratories (CLB) EBT Margin (2022 - 2026)

Core Laboratories' EBT Margin history runs 5 years deep, the most recent figure standing at 0.82% for Q1 2026.

• On a quarterly basis, EBT Margin fell 229.0% year-over-year to 0.82% in Q1 2026; TTM through Mar 2026 was 8.21%, a 7.0% decrease from a year earlier, with the FY2025 full-year figure at 8.72%, down 10.0% from the prior year.
• EBT Margin eased to 0.82% in Q1 2026 per CLB's latest filing, from 9.56% in the prior quarter.
• Across five years, EBT Margin topped out at 13.59% in Q3 2025 and bottomed at 0.82% in Q1 2026.
• The 5-year median for EBT Margin is 9.16% (2022), against an average of 7.96%.
• Across the five-year window, EBT Margin jumped 485 bps in 2023 and slumped 247 bps in 2025, its largest moves.
• Year by year, EBT Margin stood at 9.83% in 2022, then decreased by 13 bps to 8.55% in 2023, then gained by 4 bps to 8.93% in 2024, then rose by 7 bps to 9.56% in 2025, then plunged by 109 bps to 0.82% in 2026.
• Per Business Quant, the three latest CLB EBT Margin figures stand at 0.82% (Q1 2026), 9.56% (Q4 2025), and 13.59% (Q3 2025).